Global Morphine Market Size & Growth Analysis Report, 2020-2026
The global morphine market is
anticipated to showcase considerable growth during the forecast period. The
increase in the number of product launches by the key market players is a key
factor driving the growth of the global morphine drug market. Morphine is a
kind of drug given to the patient in the form of capsules and tablets by mouth
and injection through the skin. The opioid is a more effective treatment used
in pain management to offer general and palliative care. Rising in legal
approvals of opioids or opium for developing medicines in different
under-developed nations by the government is one of the key opportunities for
new and for existing players as well to expand their business across the
globe.
To Request a Sample of our Report on Global Morphine Market: https://www.omrglobal.com/request-sample/morphine-market
These players are actively engaged in making new product
launches which in turn is driving the growth of the global morphine market. For
instance, in August 2019, Upsher-Smith Laboratories, LLC had launched Morphine
Sulfate Tablets, CII, 15, and 30 mg. According to the IQVIA, the morphine
sulfate tablet market had US sales of approximately $49 million for the 12
months ending June 2019. In March 2019, Piramal Critical Care had launched
Morphine Sulfate injection with Mitigo trademark in the US. The launched
morphine sulfate injection is used for the treatment of intractable chronic
pain. The injection has been launched in 10 mg/ml and 25 mg/ml concentrations.
The company had launched this injection to diversify its presence in the field
of anesthesia, pain management, and intrathecal therapy.
In January 2017, Lupin, Ltd. had launched its US FDA approval for morphine sulfate ER tablet (in strengthening 15 mg, 30 mg, 60 mg, 100 mg, and 200 mg). Morphine sulfate ER tablet is indicated for the management of pain severe enough to require daily, timely, long-term opioid treatment and for which the use of the alternative treatment options are inadequate.
A full
Report of Global Morphine Market is Available at: https://www.omrglobal.com/industry-reports/morphine-market
Global
Morphine Market Segmentation
By
Type
·
Capsules
·
Oral Tablets
· Injection
By Application
·
Cough Suppressant
·
Diarrhea Suppressant
·
Anesthesia
·
Others
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest oF APAC
Rest of The World
·
Latin
America
·
The
Middle East and Africa
Company
Profiles
·
Allergan
PLC
·
Alcaliber
S.A.
·
Daiichi
Sankyo, Inc.
·
Macfarian
Smith, Ltd. (A Part of Johnson Matthey PLC’s Fine Chemicals Division)
·
Mallinckrodt
PLC
·
Manus
Aktteva Biopharma LLP
·
Mylan
N.V.
·
Mayne
Pharma Group, Ltd.
·
Pfizer,
Inc.
·
Purdue
Pharma LP
·
Sanofi
S.A.
·
Sun
Pharmaceuticals Industries, Ltd.
·
Taj
Pharmaceuticals, Ltd.
·
Takeda
Pharmaceutical Co. Ltd.
·
Teva
Pharmaceutical Industries, Ltd.
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/morphine-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment